Building upon these precedents, we anticipated that AI could similarly extract subtle information from pre-treatment WSIs of advanced GC patients, thus enabling the development of predictive models for the response of PD-1 inhibitors combined chemotherapy. The gene discussed is PDCD1; the disease is gastric cancer.